Company: MRT
Filing Date: 2025-08-11
Form Type: F-3
Source: 0001213900-25-074325
Chunk: 15

Company: Marti Technologies, Inc.
Filing Date: 2025-08-11
Form: F-3
Chunk 15
---
 of factors you should carefully consider before deciding to invest in the securities offered hereby.                                                                                            |
| Market for our ordinary shares                                        |     | Our Ordinary Shares are listed on the NYSE American under the symbol “MRT.”                                                                                                                                                                                                                                                                                                                                                                                                 |

<div align='center'>4

RISK FACTORS</div>

Investment in any securities offered pursuant to this prospectus and the applicable prospectus supplement involves risks. Before deciding whether to invest in our securities, you should carefully consider the risk factors described in our most recent Annual Report on Form 20-F incorporated by reference into this prospectus, our updates, if any, to those risk factors in our reports on Form 6-K incorporated by reference into this prospectus, all other information contained or incorporated by reference into this prospectus, as updated by our subsequent filings under the Exchange Act, and the risk factors and other information contained in the applicable prospectus supplement and any applicable free writing prospectus. The occurrence of any of these risks might cause you to lose all or part of your investment in the offered securities. There may be other unknown or unpredictable economic, business, competitive, regulatory or other factors that could have material adverse effects on our future results. Past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. If any of these risks actually occurs, our business, financial condition, results of operations or cash flow could be seriously harmed. This could cause the trading price of our securities to decline, resulting in a loss of all or part of your investment. Please also carefully read the section titled “Cautionary Note Regarding Forward- Looking Statements” included herein and included in our most recent Annual Report on Form 20-F and our updates, if any, to that section in our reports on Form 6-K incorporated by reference into this prospectus.

<div align='center'>5

USE OF PROCEEDS</div>

We are registering the resale
of our securities by the Selling Securityholders. All of the Ordinary Shares offered by the Selling Securityholders pursuant to this prospectus
and any applicable prospectus supplement will be sold by the Selling Securityholders for their respective accounts. We will not receive
any of the proceeds from these sales.

The Selling Securityholders
will pay all incremental selling expenses relating to the sale of their Ordinary Shares, including underwriters’ or agents’
commissions and discounts, brokerage fees, underwriter marketing costs and all reasonable fees and expenses of any legal counsel representing
the Selling